Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 12.05M
March 31, 2026 -4.122M
December 31, 2025 7.252M
September 30, 2025 0.301M
June 30, 2025 4.715M
March 31, 2025 -4.69M
December 31, 2024 4.675M
September 30, 2024 7.523M
June 30, 2024 4.408M
March 31, 2024 -11.78M
December 31, 2023 6.035M
September 30, 2023 9.617M
June 30, 2023 1.297M
March 31, 2023 6.975M
December 31, 2022 9.493M
September 30, 2022 -3.275M
June 30, 2022 -1.934M
March 31, 2022 -5.997M
December 31, 2021 0.581M
September 30, 2021 1.395M
June 30, 2021 -1.392M
March 31, 2021 -1.816M
December 31, 2020 3.492M
September 30, 2020 3.336M
June 30, 2020 -3.872M
Date Value
March 31, 2020 0.196M
December 31, 2019 6.877M
September 30, 2019 6.02M
June 30, 2019 1.246M
March 31, 2019 -1.121M
December 31, 2018 7.992M
September 30, 2018 0.318M
June 30, 2018 -1.594M
March 31, 2018 -5.472M
December 31, 2017 1.262M
September 30, 2017 2.662M
June 30, 2017 -2.703M
March 31, 2017 -3.556M
December 31, 2016 6.782M
September 30, 2016 6.639M
June 30, 2016 -3.588M
March 31, 2016 -2.815M
December 31, 2015 1.255M
September 30, 2015 4.359M
June 30, 2015 -2.598M
March 31, 2015 -3.855M
December 31, 2014 2.690M
September 30, 2014 4.072M
June 30, 2014 -1.879M
March 31, 2014 -2.395M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Cencora, Inc. 2.428B
Abbott Laboratories 1.991B
Align Technology, Inc. 157.09M
AngioDynamics, Inc. -18.48M
Accuray, Inc. 1.074M